Phase I Study of Ex Vivo Expanded/Activated Gamma Delta T-cell Infusion Following Haploidentical Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 16 Jan 2019
At a glance
- Drugs Allogeneic-gamma-delta-T-cell-therapy (Primary)
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Haematological malignancies; Myelodysplastic syndromes; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 07 Jan 2019 Planned initiation date changed from 1 Jan 2019 to 15 Feb 2019.
- 16 Oct 2018 Planned initiation date changed from 1 Nov 2018 to 1 Jan 2019 according to an Incysus Therapeutics media release.
- 16 Oct 2018 According to an Incysus Therapeutics media release, this trial expected to begin in early 2019.